Cargando…
Long-chain omega-3 polyunsaturated fatty acids are reduced in neonates with substantial brain injury undergoing therapeutic hypothermia after hypoxic–ischemic encephalopathy
Hypoxic–ischemic encephalopathy (HIE) is a major cause of neonatal morbidity and mortality. Although therapeutic hypothermia is an effective treatment, substantial chronic neurological impairment often persists. The long-chain omega-3 polyunsaturated fatty acids (PUFAs), docosahexaenoic (DHA) and ei...
Autores principales: | Dyall, Simon C., Nessel, Isabell, Sharpe, Jennine A., Yip, Ping K., Michael-Titus, Adina T., Shah, Divyen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498768/ https://www.ncbi.nlm.nih.gov/pubmed/37712085 http://dx.doi.org/10.3389/fneur.2023.1231743 |
Ejemplares similares
-
Lipid Profiles from Dried Blood Spots Reveal Lipidomic Signatures of Newborns Undergoing Mild Therapeutic Hypothermia after Hypoxic-Ischemic Encephalopathy
por: Nixon, Rebekah, et al.
Publicado: (2021) -
Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia
por: Michniewicz, Barbara, et al.
Publicado: (2020) -
Improving the Timeliness and Safety of Therapeutic Hypothermia for Hypoxic–Ischemic Encephalopathy
por: Smith, Hannah N., et al.
Publicado: (2020) -
Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: McAdams, Ryan M., et al.
Publicado: (2020) -
Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy
por: Kim, John J, et al.
Publicado: (2013)